Lateral Flow Test Strip for oxLDL/β2GPI Complex Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting the oxLDL/β2GPI complex, such as ELISA, require high experimental skill and are not suitable for high-throughput analysis due to laborious procedures and the need for repeated reagent additions and washing steps.

Innovation Solution

A lateral flow assay using a test strip with a first binding component that specifically binds to the oxLDL/β2GPI complex, such as an anti-β2GPI antibody, and a second binding component that labels the captured complex, enabling quicker and more sensitive detection without requiring extensive technical expertise.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If ELISA method is used to detect oxLDL/β2GPI complex, then detection sensitivity can be achieved, but the procedure becomes laborious and requires high experimental skill

Engineering Contradiction:
Improvedetection sensitivityVSAvoidexperimental skill requirement
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces the manual mechanical operations of ELISA (repeated reagent additions, incubations, and washings) with a lateral flow assay system that uses capillary action and pre-assembled test strips. This substitution eliminates the need for skilled manual manipulation while maintaining detection sensitivity through the use of specific antibodies and labeled detection complexes.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The lateral flow test strip is designed to perform the detection function autonomously without requiring operator intervention for each step. The sample automatically flows through the strip via capillary action, reagents are pre-loaded, and the detection reaction occurs automatically, making the system self-sufficient and eliminating the need for high experimental skill.

Inventive Principle:
Principle #25Self-service

2Measurement precision

If ELISA method is used to detect oxLDL/β2GPI complex, then detection can be performed, but it is not suitable for high-throughput analysis due to laborious procedures

Engineering Contradiction:
Improvedetection capabilityVSAvoidhigh-throughput capability
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The detection function is segmented into independent lateral flow test strips, each capable of autonomous operation. This segmentation allows multiple samples to be processed simultaneously using identical simple procedures, enabling high-throughput analysis without the laborious repeated steps required by ELISA for each sample.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The lateral flow assay skips the time-consuming intermediate steps of ELISA (multiple washings, reagent additions, and incubations) by using a continuous flow system where the sample moves rapidly through predetermined zones. This rushing through of detection steps maintains detection capability while dramatically increasing processing speed and throughput.

Inventive Principle:
Principle #21Skipping (Rushing through)

3Measurement precision

If conventional detection methods are used, then detection can be performed, but the procedure is time-consuming and complex

Engineering Contradiction:
Improvedetection accuracyVSAvoiddetection time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The test strip is pre-assembled with all necessary components (capture antibodies, detection antibodies, labels, and control elements) in their correct positions before use. This preliminary preparation eliminates the need for time-consuming setup and procedural steps during actual detection, allowing rapid and accurate results while maintaining detection accuracy through pre-optimized reagent ratios and positioning.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method allows for easier and faster detection of the oxLDL/β2GPI complex with a broader dynamic range compared to conventional ELISA methods, facilitating quicker and more accurate monitoring of arteriosclerosis progression without the need for professional skill.

Implementation Method 1

a step of capturing the oxLDL/β2GPI complex in the test sample in a predetermined position on the test strip by a first binding component that binds to the oxLDL/β2GPI complex

Methodology Applied
Scientific EffectAntigen-antibody binding:

Implementation Method 2

a step of labeling the oxLDL/β2GPI complex captured in the predetermined position on the test strip by making a second binding component comprising a labeling agent be bound to the captured oxLDL/β2GPI complex

Methodology Applied
Scientific EffectAntigen-antibody binding:

Implementation Method 3

uses a test strip for lateral flow assay

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentUS20220205997A1A detection method for detecting an oxidized LDL/Beta2GPI complex and a detection kit therefor
Publication Date: 2022.06.30 UNIV OKAYAMA
  • US20220205997A1 patent drawing
  • US20220205997A1 patent drawing
  • US20220205997A1 patent drawing

AI summary

The object of the present invention is to provide an easy and quick detection method for detecting an oxLDL/β2GPI complex in biological samples, and a detection kit therefor. The present invention attains this object by providing a detection method for detecting an oxLDL/β2GPI complex, which uses a test strip for lateral flow assay, comprising a step of capturing the oxLDL/β2GPI complex in the test sample in a predetermined position on the test strip by a first binding component that binds to the oxLDL/β2GPI complex; and a step of labeling the oxLDL/β2GPI complex captured in the predetermined position on the test strip by making a second binding component comprising a labeling agent be bound to the captured oxLDL/β2GPI complex, and a detection kit therefor.